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Abstract
Objectives: Despite robust growth in participation in marathons and endurance sports among older individuals, guidance
regarding pre-participation cardiovascular evaluation of these athletes is lacking. The objective of this study was to assess
the utility of currently available pre-participation cardiovascular evaluation guidelines as applied to a cohort of older novice
endurance athletes.
Methods: We applied data from 1457 novice runners and endurance athletes aged 35 years and older to two pre-participation
screening tools, the American Heart Association/American College of Sports Medicine Pre-Participation Questionnaire and
the 2001 Working Group recommendations for pre-participation screening of masters athletes (2001 Masters).
Results: Application of the American Heart Association/American College of Sports Medicine Pre-Participation Questionnaire
identified 42.1% for which pre-participation cardiovascular evaluation was indicated. Of those who met criteria, 51.5%
reported completion of a healthcare evaluation. Application of the 2001 Masters guidelines identified 75.2% who qualified for
pre-participation electrocardiogram and 34.0% for pre-participation stress testing. Of those who met 2001 Masters criteria
for pre-participation testing, 43.7% and 24.6% underwent recommended electrocardiogram and stress testing, respectively.
While there was modest concordance with recommendations for pre-participation evaluations based on both American
Heart Association/American College of Sports Medicine Pre-Participation Questionnaire and 2001 Masters, only athlete age
was independently associated with completion of a pre-participation healthcare evaluation and only athlete age and athlete’s
participation in marathons were independently associated with pre-participation stress testing.
Conclusion: Among older novice endurance athletes, application of the American Heart Association/American College of
Sports Medicine Pre-Participation Questionnaire and 2001 Masters guidelines identifies a significant percentage of athletes
for whom pre-participation evaluation and testing are recommended. Concordance with these guidelines was modest and
providers were primarily influenced by athlete age and competitive goals when planning pre-participation testing. Given the
rarity of cardiovascular events among older participants in endurance events, the cost-effectiveness of the American Heart
Association/American College of Sports Medicine Pre-Participation Questionnaire and 2001 Masters guidelines may be
unacceptable for general use.
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Introduction
A growing body of evidence supports the health benefits of
regular exercise in the aging population.1–4 As a result, there
is a universal acceptance of the concept that the overall benefits of exercise outweigh the risks of participation.5–8
However, the occasional media reports of runners dying suddenly while competing in endurance events bring to the forefront the question of how to screen individuals for risk of
complications related to participation.9
In 2012, a record 850 marathons were held in the United
States alone, compared to approximately 300 such events in
2000.10 The growth of participation in endurance events is
likely due in large part to the numerous health benefits exercise has been shown to offer.8,11–15 Not surprisingly, the growth
in participation in marathons and endurance sports has resulted
in parallel increases in the number of older athletes competing
in these events.15–18 The population of athletes aged 35 years
and older, so-called “masters-age” athletes, represents a challenge for healthcare providers who are asked to make decisions regarding assessments of cardiovascular risk associated
with participation in such physically demanding events.8,19–22
There are currently no validated tools to help physicians
assess participation risk in masters athletes because most
tools are geared toward screening younger participants.23–27
In contrast to younger elite athletes, aging athletes are at particular risk of exercise-induced cardiovascular events related
to undiagnosed coronary artery disease (CAD).5,9 To help fill
this void, the American Heart Association (AHA) and the
American College of Sports Medicine (ACSM) developed
the American Heart Association/American College of Sports
Medicine Pre-Participation Questionnaire (AAPQ) to screen
for cardiovascular risk among sedentary individuals who
desire to initiate a fitness program.25 In addition, the 2001
Masters Athletics Working Group has previously developed
a set of pre-participation guidelines aimed at higher-level
masters athletes who desire to participate in more competitive sporting events (2001 Masters).28 The latter were the
recommendations of a working group with representation
from the World Heart Federation, the International Federation
of Sports Medicine, and the AHA. The goal of both the 2001
Masters and the AAPQ guidelines is to enable cost-effective
screening of novice athletes for high-risk characteristics that
warrant further cardiovascular evaluation.28
Little is known about these screening tools’ effectiveness
in identifying athletes who will ultimately suffer sportrelated cardiovascular events. In addition, there is little evidence as to whether these tools are being used by healthcare
providers for guidance in pre-participation evaluation of
older individuals who plan to begin training for endurance
events. In this study, we applied the AAPQ and 2001 Masters
pre-participation screening tools to self-reported health risk
and assessment data from a population of novice masters
runners and triathletes. Our goal was to determine whether
the use of these tools in a population of older novice runners
would “screen-in” a reasonable percentage of these athletes
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to be referred for further pre-participation cardiovascular
assessment. In addition, we assessed whether pre-participation testing was indeed being applied to individuals who
“screen-in” for further workup based on these tools. Finally,
we assessed the factors that were independently related to
the performance of pre-participation evaluations in our population of older runners.

Methods
We designed the Masters Athletic Study of Training and
mEdical characteristics of older RunnerS (MASTERS) Study
as an ongoing longitudinal, Internet-based survey of training
and health aspects of runners aged 35 years and older. The
survey consists of 50 questions concerning health issues,
training duration and intensity, and perceptions regarding
health benefits and risks of endurance sports. The study was
launched from a secure, Health Insurance Portability and
Accountability Act (HIPAA)-compliant website (Survey
Monkey, Palo Alto, CA) in July 2013. Respondents were
recruited from eligible runners who responded to an advertisement in a national running publication (Running Times
Magazine, Rodale Press, Emmaus, PA) and on multiple running-related Internet message boards. For this study, we
included respondents who met criteria as “novice” runners:
those who reported that they began a recreational or competitive running career within the past 5 years. These novice runners were asked about specific aspects of their health histories,
medicine usage, and training characteristics and were also
queried about medical evaluations within the past 5 years, a
time period that coincided with their reported running careers.
The AAPQ was designed to identify individuals embarking
on a fitness program who are of high enough risk to warrant an
evaluation by a healthcare provider prior to participation.25
The AAPQ is a one-page self-assessment tool with questions
covering three areas: cardiovascular history, symptoms, and
cardiovascular risk factors (see Appendix 1). If a subject
responds positively to any of the statements regarding cardiac
history or symptoms, or to two or more of the statements
regarding risk factors, a recommendation is made for a preparticipation evaluation (PPE). For this study, questions
applied to the AAPQ were based on the relationship of the
survey question to the AAPQ questionnaire topic. All but 6 of
the 30 questions could be answered using survey questions;
those that could not be applied included five questions in section 1: three related to symptoms of chest pain, breathlessness,
or syncope; one question regarding current pregnancy; and
one question regarding current musculoskeletal problems. In
addition, one question in section 2 related to obesity could not
be answered from the survey responses.
The 2001 Masters pre-participation guidelines were
designed to assess competitive sports participants at the masters level and, as a result, the recommendations regarding
specific pre-participation testing are more aggressive than
the AAPQ. The 2001 Masters makes three specific recommendations: (1) pre-participation stress test for men aged
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>40 years and women aged >50 years who also have one of
the following conditions: hypercholesterolemia, systemic
hypertension, current or recent cigarette smoking, diabetes
mellitus, or history of myocardial infarction or sudden cardiac death in a first-degree relative aged <60 years; and (2)
pre-participation stress testing for all athletes aged ⩾65 years;
and (3) pre-participation electrocardiogram (ECG) for all
athletes male and female aged >40 years. All criteria required
to determine the need for pre-participation assessment per
the 2001 Masters guidelines could be applied to our questionnaire using specific survey responses. For assessment of
independent predictors of PPE, in addition to information
applied to AAPQ and AHA Masters, we also utilized questions regarding whether or not respondents participated in
marathon distance races or longer, and the respondents’ perceived risk of dying in a running race (from 1:1000 to
1:10,000,000).
Categorical data were evaluated using chi-square analysis. Independent variables of the performance of pre-participation evaluation were identified using multivariable logistic
regression analysis. For all assessments, a p value of <0.05
was considered significant.
This study, including a waiver of informed consent, was
approved by the Institutional Review Board of Lehigh Valley
Health Network, Allentown, PA.

Results
Of the 5850 survey respondents, a total of 1457 were defined
as “novice” runners and are included in the analysis.
Demographic and health details of the cohort are summarized in Table 1. Of note, 485 (33%) respondents reported
they had previously run in a marathon or ultra-distance
event, while 230 (15.8%) had participated in a triathlon.
Results of the application of the AAPQ pre-participation
guidelines are summarized in Table 2. After applying AAPQ
criteria, we identified 614/1457 (42.1%) for whom PPE was
indicated. Of those who met the criteria for PPE, slightly
more than half reported a physician visit within the past
5 years. A significantly greater percentage of athletes who
met AAPQ criteria reported a physician visit, ECG, stress
test, and performance of coronary calcium scoring or carotid
ultrasonography within the past 5 years compared to those
athletes who did not meet AAPQ criteria for PPE.
The application of the 2001 Masters PPE guidelines to the
survey population is summarized in Table 3. Of the 1457
novice runners, 1096 (75.2%) of respondents met criteria for
the performance of pre-participation ECG and 495 (34.0%)
of respondents met criteria for pre-participation stress testing. Of those athletes who met criteria for pre-participation
ECG and stress testing by the 2001 Masters guidelines, 458
(43.7%) and 122 (24.6%) reported having undergone these
tests past 5 years, respectively. In comparison, 105 (29.8%)
and 111 (11.5%) of athletes who did not meet the criteria had
undergone ECG and stress testing, respectively.

Table 1. Participant demographics.
Characteristics (n = 1457)
Age
Mean, years (range)
Gender
Male
Female
Risk factors
Hypertension
Hypercholesterolemia
Diabetes mellitus
History MI
History of cardiovascular disease
 Family history of CVD
Ever smoked
Running habits
 Have run marathon/
ultra-marathon
 Participate in triathlons

N

%

44.5 (35–86)
940
517

64.5
35.5

167
333
27
6
34
577
578

11.5
22.9
1.9
0.4
2.3
39.6
39.7

485

33.3

230

15.8

MI: myocardial infection; CVD: cardiovascular disease.

Table 2. Results of application of AAPQ pre-participation
guidelines.
Variable

AAPQ screen-ina
(n = 614)

AAPQ screenouta (n = 843)

p value

Pre-participation
doctor visit
ECG
Stress test
CAC/CIMT

316 (51.5)

335 (36.4)

<0.001

299 (48.7)
136 (22.1)
62 (10.1)

277 (30.1)
97 (10.5)
27 (3.2)

<0.001
<0.001
<0.001

aValues listed as n (%).
AAPQ: American Heart Association/American College of Sports Medicine
Pre-Participation Questionnaire; CAC: coronary artery calcium; CIMT:
carotid intima media thickness; ECG: electrocardiogram.

Table 3. Performance of ECG and stress testing, stratified by
AHA 2001 Masters guidelines.

ECG
Stress test

Screen-in

Screen-out

p value

458/1048 (43.7)
122/495 (24.6)

105/352 (29.8)
111/962 (11.5)

<0.001
<0.001

ECG: electrocardiogram; AHA: American Heart Association.

It is unlikely that the majority of decisions by novice runners and their physicians regarding PPE were made using
screening tools such as AAPQ or the 2001 Masters guidelines
as references. The factors considered in decisions regarding the
need for PPE in our population are unclear. Therefore, we
assessed the independent drivers of the use of pre-participation
medical evaluation and stress testing using multivariable logistic regression analysis of selected components of AAPQ/2001
Masters recommendations. The only independent driver of the
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Figure 1. Forest plot representation of independent predictors of pre-participation healthcare provider evaluation based on AAPQ
simulation. CAD: coronary artery disease; “risk of Dying in Race”: respondents’ numerical perception of the risk of death in running races.

Figure 2. Forest plot representation of independent predictors of pre-participation stress testing based on 2001 Masters simulation.
CAD: coronary artery disease; “risk of Dying in Race”: respondents’ numerical perception of the risk of death in running races.

performance of pre-participation medical evaluation was
increasing age (odds ratio (OR), 1.071; 95% CI (95% confidence interval), 1.020–1.123; Figure 1). The independent drivers of the performance of pre-participation stress testing were
athlete age (OR, 1.055; 95% CI, 1.026–1.084) and athlete’s
report of participation in races of marathon length or greater
(OR, 1.521; 95% CI, 1.009–2.294; Figure 2). Traditional risk
factors such as hypertension, diabetes, and hypercholesterolemia did not appear to influence these pre-participation
screening decisions.

Discussion
The growing popularity of endurance sports is exemplified
in the explosion of the number of marathons conducted in
the United States.10,15,29 Since 2001, US marathon participants have nearly doubled from 295,000 to 425,000.30 The
increase in endurance sport participation over the past decade has been paralleled by escalating participation by older
competitors, including older novice participants.15–18,25
These athletes are at increased risk of exercise-related cardiovascular events, specifically acute coronary ischemia
related to underlying CAD.11,13,19,31 The majority of national

and international pre-participation evaluation guidelines
have focused on screening younger (aged <35 years), elite
competitive athletes, primarily for congenital cardiovascular
abnormalities that predispose them to sudden cardiac
death.20,23,24,26,27 In contrast, the older competitive athlete has
distinctly different concerns than younger competitors and
requires a different diagnostic approach, focusing on risk
related to subclinical CAD.23–27,32
The need for effective and usable tools for pre-participation
screening of novice recreational and non-elite athletes led to
the development of the AAPQ and 2001 Masters pre-participation guidelines. The AAPQ was originally designed to aid
non-medical personnel in identifying persons at risk of cardiovascular complications resulting from the initiation of an exercise program.25 The 2001 Masters pre-participation guidelines
were designed to identify risk in older athletes who wish to
participate in high-level competitive athletics.28 A recent study
applied the AAPQ to participants of the National Health and
Nutritional Examination Survey (NHANES) to determine the
rate of referral for pre-participation medical evaluation in this
population.33 Interestingly, application of AAPQ would have
resulted in a physician referral rate of greater than 90% of
NHANES participants, making it an ineffective screening tool
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for this population. Importantly, the NHANES population represents a relatively sedentary, non-physically fit population,
including less than 40% of respondents reporting being even
minimally physically active.33 Thus, the NHANES population
appears to be distinctly different from our population of novice marathoners and endurance athletes, all of whom had
recently embarked on a high-level endurance exercise regimen. Little data are available regarding the typical risk factor
profile of older marathoners and endurance athletes or the performance of currently available screening tools applied to this
population. Not surprisingly, AAPQ applied to our population
performed comparatively better, as it identified a much more
reasonable percentage of individuals for pre-participation
medical evaluation versus that of its application to NHANES
(40% versus >90%). When the 2001 Masters pre-participation
guidelines were applied to our population, they likewise performed reasonably well, with just over one-third of athletes
identified as needing pre-participation stress testing. Taken
together, the application of current guidelines for pre-participation evaluation to a cohort of novice endurance athletes
yields a significant but reasonable percentage of athletes identified as being of high enough risk for exercise-associated cardiovascular events to warrant pre-participation evaluation and
testing. These data in no way validate AAPQ or 2001 Masters
as effective screening tools for the pre-participation assessment of older endurance athletes; at present, we cannot evaluate the sensitivity and specificity of these tools for identifying
athletes at risk for exercise-related events.
We did not assess whether surveyed athletes or their
healthcare providers utilized available screening tools to
make decisions regarding PPE. When we examined concordance with guidelines, we did find that significantly
more athletes who met either AAPQ or 2001 Masters criteria for evaluation and testing underwent these indicated
procedures compared to those who did not meet the criteria. However, two interesting findings should be noted:
first, the percentage of those individuals undergoing appropriate evaluation and testing was modest, with just over
half of those “screening in” by AAPQ criteria undergoing
pre-participation medical evaluation and less than onequarter of those “screening in” by 2001 Masters criteria
undergoing pre-participation stress testing. Second, a significant percentage of athletes identified by AAPQ and
2001 Masters as not needing PPE nonetheless underwent
pre-participation evaluation regardless. Regardless, assuming AAPQ and/or 2001 Masters accurately identify individuals for which PPE is appropriate, our data suggest that
stringent use of these guidelines would lead to the identification and pre-participation evaluation of a substantial
number of athletes in order to successfully identify those
athletes who are truly at risk of endurance sport-related cardiac events. Assuming the rate of endurance sport-related
sudden cardiac death in older athletes is 1:50,00034,35 and
PPE accurately identifies individual at risk of exerciserelated cardiovascular events, application of AAPQ and
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2001 Masters would result in the identification of 15,000–
20,000 athletes who would require screening in order to
identify one individual who ultimately would suffer sudden
cardiac arrest during an endurance event. The economic
impact of a screening program with these requirements
makes it an unattractive option for PPE of older endurance
athletes.
Other than available guidelines for PPE, little is known
about the specific variables that determine both decisions by
older athletes to seek a pre-participation medical consult and
decisions by athletes and their providers to perform pre-participation diagnostic testing. Using multivariable logistic
regression analysis, we found that the only independent driver
of the need for PPE by a healthcare provider was increasing
age. In contrast, independent drivers of pre-participation
stress testing included both increasing age and participation
in marathon or ultra-marathon distance events. That increasing age is identified as a risk factor for cardiovascular complications of endurance sports and, hence, drives PPE and testing
is not surprising.29,36,37 The reason that marathon participation
also led to more frequent use of stress testing is less
obvious—it is possible that both athletes’ and healthcare providers’ perceptions of the extreme physical nature, and resultant cardiovascular risk, of these events led to more testing.
Conspicuously absent as independent drivers for testing were
hypertension, diabetes, hypercholesterolemia, smoking history, and family history of CAD. A reasonable interpretation
of this finding is that older athletes and their care providers
are basing decisions regarding pre-participation CAD screening more on the perceived risks of the training or of the endurance events themselves, rather than on the risk factor profile
of the participant.
While the rates of “screening in” by both AAPQ and the
2001 Masters guidelines are promising candidate screening
tools for the identification of high-risk older endurance athletes requiring PPE; further study is required both to validate
the accuracy of these tools for identifying at-risk athletes and
to demonstrate that cardiovascular complications of endurance sport participation can be prevented in a cost-effective
manner using the results of these assessments. While sudden
deaths occurring among participants of endurance events
such as marathons and triathlons receive significant media
attention and draw attention to the safety of participation in
these events, cardiovascular complications of endurance
sports remain rare occurrences.5 Thus, it is critical that a
thorough cost assessment of the application of pre-participation screening tools to older athletes is a focus of future studies in this area.
There are several limitations to our study. Perhaps most
important, this was a survey completed by runners drawing
on recall of the past 5 years. Thus, we made the assumption
that the survey respondents were accurate in their recall of the
timing of both the start of their endurance sport careers and
their medical evaluations and testing. Without comprehensive information regarding the timing of medical evaluations
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with regard to completion of endurance events, we cannot be
sure that, although both occurred within the past 5 years, the
relationship of the evaluations to initiation of training or racing was proximate and valid. Optimally, an assessment of
runners with less than 1 year of experience or those anticipating initiation of a training program may have yielded more
accurate and robust results, but such an assessment was not
possible with our current survey population. Additionally, our
survey questions did not conform to the complete AAPQ;
specifically, we had no data regarding symptoms in our
respondents. We made the assumption that, because our
respondents were embarking on an endurance sport career
(including a significant percentage of participants in marathons and triathlons), any presence of symptoms would have
prompted a medical evaluation long before the initiation of
this career. Admittedly, omitting these questions may have
resulted in an under-estimate of the percentage of respondents who would be referred for PPE on the basis of AAPQ;
however, we believe the overall magnitude of this under-estimate is likely to be small. In addition, because this was an
online survey, it may be pooling a specific subset of the
endurance athletes and thus not reflect the risk profile or preparticipation workup of the general novice endurance athlete
population. The large number of respondents helps manage,
but does not completely mitigate, this possibility.

Conclusion
Applying AAPQ and the 2001 Masters Athlete pre-participation
guidelines to a large sample of novice runners and endurance
athletes yields a substantial percentage of athletes that are recommended for pre-participation provider evaluation and/or testing. A modest percentage of novice athletes meeting guideline
criteria for PPE actually underwent guideline-recommended
evaluations, and athlete age and competitive plans seemed to be
the major drivers for PPE. Application of currently available
guidelines for pre-participation screening of older endurance
athletes will require further refinement before they can be considered standard of care for the evaluation of novice older athletes for cardiovascular risk of endurance sports.
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Appendix 1
American Heart Association/American College of Sports Medicine Pre-Participation Questionnaire
Table 4. AHA/ACSM Health/Fitness Facility Pre-Participation Screening Questionnaire.
Assess your health needs by marking all true statements.
History
You have had:
a heart attack
heart surgery
cardiac catheterization
coronary angioplasty (PTCA)
pacemaker/implantable cardiac defibrillator/rhythm disturbance
heart valve disease
heart failure
heart transplantation
congenital heart disease
Symptoms
You experience chest discomfort with exertion
You experience unreasonable breathlessness
You experience dizziness, fainting, blackouts
You take heart medications
Cardiovascular risk factors
You are a man older than 45 years
 You are a woman older than 55 years or you have had a hysterectomy
or you are postmenopausal
You smoke
Your blood pressure is >140/90
You don’t know your blood pressure
You take blood pressure medication
Your blood cholesterol level is >240 mg/dL
You don’t know your cholesterol level
 You have a close blood relative who had a heart attack before the age
of 55 years (father or brother) or age 65 years (mother or sister)
You are diabetic or take medicine to control your blood sugar
 You are physically inactive (i.e. you get <30 min of physical activity on
at least 3 days per week)
You are >20 pounds overweight
None of the above is true.

If you marked any of the statements in this section,
consult your healthcare provider before engaging
in exercise. You may need to use a facility with a
medically qualified staff

Other health issues
You have musculoskeletal problems
You have concerns about the safety of exercise
You take prescription medications
You are pregnant
If you marked two or more of the statements in this
section, consult your healthcare provider before
engaging in exercise. You might benefit using a facility
with a professionally qualified exercise staff to guide
your exercise program

You should be able to exercise safely without
consulting your healthcare provider in almost any
facility that meets your exercise program needs

Source: Balady et al.25 (with permission).
AHA/ACSM: American Heart Association/American College of Sports Medicine; PTCA: percutaneous transluminal coronary angioplasty.

